Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04277507 · ClinicalTrials.gov registry record · NA

Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction

A NA study of Nasal Obstruction, sponsored by Aerin Medical.

Completed
Registry status
NA
Development phase
122
Enrollment target
10
Study locations

NCT04277507 is a NA study of Nasal Obstruction that has completed, run by Aerin Medical. The registered enrollment target is 122 participants, below the 136-participant average among 4 other Nasal Obstruction trials with a reported enrollment target (10% lower). The trial reports 10 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04277507, a NA study of Nasal Obstruction, has completed, sponsored by Aerin Medical.

COMPLETED
Registry status
NA
Development phase
122 participants
Enrollment target
10
Study locations

Study Summary

Post-market study to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for nasal airway obstruction

Conditions Studied

Interventions

  • DEVICE Vivaer Stylus

Study Locations (10)

Florida

  • ENT Associates of South Florida - Boca Raton
  • ENT Associates of South Florida - Plantation

Texas

  • UT Physicians Otorhinolaryngology - Texas Medical Center - Houston
  • ENT Associates of Texas - McKinney

Alabama

  • Alabama Nasal and Sinus Center - Birmingham

Arizona

  • Arizona Desert ENT Specialists - Goodyear

California

  • Sacramento ENT - Roseville

Illinois

  • Chicago Nasal and Sinus Center - Chicago

Louisiana

  • Baton Rouge General / Sinus and Nasal Specialists of Louisiana - Baton Rouge

New Jersey

  • Advocare Aroesty ENT Associates - Mount Arlington

Trial Details

FieldValue
Enrollment Target 122 participants
Start Date 2020-02-07
Est. Completion 2024-10-11
Phase NA

Sponsor

Aerin Medical

14 total trials

What the Registry Record Tells You About NCT04277507

The ClinicalTrials.gov registry entry for NCT04277507 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 136-participant average among 4 other Nasal Obstruction trials with a reported enrollment target (10% lower). The listed sponsor is Aerin Medical, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Nasal Obstruction appearing as the primary indexed condition, and to 1 intervention - of which Vivaer Stylus is the first listed.

NCT04277507 reports 10 study locations spanning 8 distinct geographic areas - top geographies include Florida, Texas, Alabama.

Frequently Asked Questions

What is clinical trial NCT04277507 about?

NCT04277507 is a clinical study titled "Study of the AERin Medical Vivaer® ARC Stylus for Nasal AirWAY Obstruction". Post-market study to continue to evaluate the effectiveness of the Vivaer® ARC Stylus for nasal airway obstruction

What is the current status of trial NCT04277507?

This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2020-02-07. Estimated completion is 2024-10-11.

What conditions does trial NCT04277507 study?

This clinical trial studies the following conditions: Nasal Obstruction.

What interventions are being tested in trial NCT04277507?

The interventions under investigation include: Vivaer Stylus (DEVICE).

Who is sponsoring clinical trial NCT04277507?

This trial is sponsored by Aerin Medical, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04277507 being conducted?

This trial has 10 study locations across Alabama, Arizona, California, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nasal Obstruction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.